statistiche ricercatore

Continente	#
NA - Nord America	672
AS - Asia	293
EU - Europa	271
SA - Sud America	40
AF - Africa	6
Continente sconosciuto - Info sul continente non disponibili	3
Totale	1.285

Nazione	#
US - Stati Uniti d'America	649
SG - Singapore	92
CN - Cina	79
IT - Italia	67
HK - Hong Kong	50
GB - Regno Unito	36
DE - Germania	33
SE - Svezia	33
BR - Brasile	31
RU - Federazione Russa	26
VN - Vietnam	24
FI - Finlandia	19
CA - Canada	18
ID - Indonesia	16
IE - Irlanda	14
FR - Francia	10
AT - Austria	9
IN - India	8
JP - Giappone	5
BG - Bulgaria	4
LT - Lituania	4
PL - Polonia	4
AR - Argentina	3
BE - Belgio	3
IQ - Iraq	3
KR - Corea	3
MX - Messico	3
UA - Ucraina	3
A2 - ???statistics.table.value.countryCode.A2???	2
BD - Bangladesh	2
EC - Ecuador	2
ES - Italia	2
MA - Marocco	2
NL - Olanda	2
PY - Paraguay	2
ZA - Sudafrica	2
AM - Armenia	1
AZ - Azerbaigian	1
BO - Bolivia	1
BW - Botswana	1
DK - Danimarca	1
EG - Egitto	1
EU - Europa	1
GE - Georgia	1
KH - Cambogia	1
KZ - Kazakistan	1
LB - Libano	1
LC - Santa Lucia	1
MY - Malesia	1
PE - Perù	1
PK - Pakistan	1
RO - Romania	1
SA - Arabia Saudita	1
TR - Turchia	1
TT - Trinidad e Tobago	1
UZ - Uzbekistan	1
Totale	1.285

Nome	#
Immune-inflammatory and clinicopathologic prognostic factors in a Western cohort of resected gastric cancers (GCs)	214
A user-friendly nomogram to predict relapse-free survival (RFS) in western patients with resected gastric cancer (GC)	200
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy	184
The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center	175
Clinical implications of malnutrition in the management of patients with pancreatic cancer: Introducing the concept of the nutritional oncology board	160
Exceptional response to lurbinectedin and irinotecan in BRCA-mutated platinum-resistant ovarian cancer patient: a case report	137
Could inflammatory indices and metabolic syndrome predict the risk of cancer development? Analysis from the bagnacavallo population study	125
External validation of surrogate indices of fatty liver in the general population: The Bagnacavallo study	102
Totale	1.297

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	57	0	0	0	0	0	0	9	7	10	11	8	12
2021/2022	110	0	17	1	1	8	6	3	13	8	13	15	25
2022/2023	231	25	29	13	26	25	26	7	14	38	0	13	15
2023/2024	174	4	4	12	25	25	33	11	17	2	4	14	23
2024/2025	327	3	2	7	20	69	65	27	15	42	18	17	42
2025/2026	349	56	17	36	86	113	41	0	0	0	0	0	0
Totale													1.297